Product Information
ACETAMINOPHEN 325 MG TABLET is a generic product labeled by Cardinal Health, priced at $0.0261 per EA under NDC 70000009201. Its NADAC has been published 225 times since Oct 6, 2021.
Strength
325 mg/1
Manufacturer
Cardinal HealthNDC
70000009201
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Last Updated
1/21/2026
Active Ingredients
ACETAMINOPHENApproval Type
OTC MONOGRAPH DRUG
FDA Application
M013On Market Since
5/5/2021
Price Statistics
The NADAC for ACETAMINOPHEN 325 MG TABLET has been published 225 times since Oct 6, 2021, and over the history we have for it it has risen 12.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0261 per EA |
|---|---|
| All-time high | $0.0267 (Nov 13, 2024) |
| All-time low | $0.0208 (May 18, 2022) |
| 52-week high | $0.0267 |
| 52-week low | $0.0247 |
| Median price | $0.0241 |
| Average price | $0.0241 |
| Largest weekly change | +21.2% (Jun 22, 2022) |
| Weeks tracked | 225 |
| Tracking since | Oct 6, 2021 |
Generic Alternatives
The matcher finds 8 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 8 manufacturers (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 11% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of ACETAMINOPHEN 325 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for ACETAMINOPHEN 325 MG TABLET, manufactured by Cardinal Health, is $0.0261 per EA (NDC 70000009201), effective Jan 21, 2026.
How has the price of ACETAMINOPHEN 325 MG TABLET changed over time?
Over the history we have for it, the NADAC for ACETAMINOPHEN 325 MG TABLET has risen 12.0%. It has been tracked across 225 weekly CMS publications since Oct 6, 2021.
What are the highest and lowest recorded NADAC prices for ACETAMINOPHEN 325 MG TABLET?
Since Oct 6, 2021, the NADAC for ACETAMINOPHEN 325 MG TABLET has ranged from a low of $0.0208 (May 18, 2022) to a high of $0.0267 (Nov 13, 2024), with a median of $0.0241 per EA.
Are there cheaper alternatives to ACETAMINOPHEN 325 MG TABLET?
Yes. 8 NADAC-published products share the same active ingredient, strength, and dosage form. The lowest-priced option, QC PAIN RELIEF 325 MG TABLET, is $0.0232 per EA — about 11% below ACETAMINOPHEN 325 MG TABLET.
Who manufactures ACETAMINOPHEN 325 MG TABLET?
ACETAMINOPHEN 325 MG TABLET (NDC 70000009201) is labeled by Cardinal Health, and CMS classifies it as a generic product.
Related Drugs
Same classification